• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

岩藻糖基转移酶8(FUT8)受微小RNA-122-5p(miR-122-5p)调控,并通过磷脂酰肌醇-3-激酶/蛋白激酶B(PI3K/AKT)信号通路促进肝内胆管癌的恶性进展。

FUT8 is regulated by miR-122-5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling.

作者信息

Chen Fanghua, Li Yin, Aye Ling, Wu Yingcheng, Dong Liangqing, Yang Zijian, Gao Qiang, Zhang Shu

机构信息

Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, 200032, China.

Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

出版信息

Cell Oncol (Dordr). 2023 Feb;46(1):79-91. doi: 10.1007/s13402-022-00736-y. Epub 2022 Nov 8.

DOI:10.1007/s13402-022-00736-y
PMID:36348252
Abstract

BACKGROUND

Intrahepatic cholangiocarcinoma (iCCA) is the second-most lethal primary liver cancer and its prognosis remains dismal. N-glycosylation, which is biosynthesized by a number of glycosyltransferases, plays an important role in a variety of biological processes and is associated with cancer development and progression.

METHODS

Based on our previous proteogenomic resources from an iCCA cohort of 262 patients, fucosyltransferases 8 (FUT8) showed significant prognosis relevance in iCCA. Tumor tissues from iCCA patients were used to evaluate the correlation between its expression and clinical information. Gain/loss-of-function experiments in iCCA cell lines were performed to elucidate the biological function of FUT8. In addition, its downstream pathways and post-transcriptional regulators were inferred and verified.

RESULTS

Elevated FUT8 expression was clinically associated with worse overall survival in iCCA patients. Its overexpression promoted migration, invasion and proliferation ability of iCCA cells. In addition, miR-122-5p was found to act as a post-transcriptional regulator of FUT8 and proved to inhibit FUT8 expression and then suppress the proliferation and migration ability of iCCA cell lines. Furthermore, FUT8 was observed to promote iCCA development through PI3K/AKT signaling pathway.

CONCLUSIONS

These findings demonstrated that FUT8, regulated by miR-122-5p, could be a tumor promoter of iCCA through PI3K/AKT signaling pathway.

摘要

背景

肝内胆管癌(iCCA)是致死率第二高的原发性肝癌,其预后仍然很差。N-糖基化由多种糖基转移酶生物合成,在多种生物学过程中起重要作用,并与癌症的发生和发展相关。

方法

基于我们之前来自262例iCCA患者队列的蛋白质基因组学资源,岩藻糖基转移酶8(FUT8)在iCCA中显示出显著的预后相关性。使用iCCA患者的肿瘤组织评估其表达与临床信息之间的相关性。在iCCA细胞系中进行功能获得/丧失实验,以阐明FUT8的生物学功能。此外,对其下游途径和转录后调节因子进行了推断和验证。

结果

FUT8表达升高在临床上与iCCA患者较差的总生存期相关。其过表达促进了iCCA细胞的迁移、侵袭和增殖能力。此外,发现miR-122-5p作为FUT8的转录后调节因子,可抑制FUT8表达,进而抑制iCCA细胞系的增殖和迁移能力。此外,观察到FUT8通过PI3K/AKT信号通路促进iCCA的发展。

结论

这些发现表明,受miR-122-5p调控的FUT8可能通过PI3K/AKT信号通路成为iCCA的肿瘤促进因子。

相似文献

1
FUT8 is regulated by miR-122-5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling.岩藻糖基转移酶8(FUT8)受微小RNA-122-5p(miR-122-5p)调控,并通过磷脂酰肌醇-3-激酶/蛋白激酶B(PI3K/AKT)信号通路促进肝内胆管癌的恶性进展。
Cell Oncol (Dordr). 2023 Feb;46(1):79-91. doi: 10.1007/s13402-022-00736-y. Epub 2022 Nov 8.
2
MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.MUC13通过表皮生长因子受体/磷脂酰肌醇-3激酶/蛋白激酶B通路促进肝内胆管癌进展。
J Hepatol. 2020 Apr;72(4):761-773. doi: 10.1016/j.jhep.2019.11.021. Epub 2019 Dec 16.
3
CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN/AKT pathway in intrahepatic cholangiocarcinoma.环状锌指蛋白 215 通过失活 PTEN/AKT 通路促进肝内胆管癌的生长和转移。
J Exp Clin Cancer Res. 2023 May 18;42(1):125. doi: 10.1186/s13046-023-02699-w.
4
miR-885-5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma.miR-885-5p通过靶向IGF2BP1和GALNT3抑制人肝内胆管癌的增殖和转移。
Mol Carcinog. 2020 Dec;59(12):1371-1381. doi: 10.1002/mc.23262. Epub 2020 Oct 14.
5
ST3GAL1 Promotes Malignant Phenotypes in Intrahepatic Cholangiocarcinoma.ST3GAL1 促进肝内胆管癌的恶性表型。
Mol Cell Proteomics. 2024 Sep;23(9):100821. doi: 10.1016/j.mcpro.2024.100821. Epub 2024 Jul 26.
6
miR-181b-5p Promotes the Progression of Cholangiocarcinoma by Targeting PARK2 via PTEN/PI3K/AKT Signaling Pathway.miR-181b-5p 通过靶向 PARK2 经 PTEN/PI3K/AKT 信号通路促进胆管癌的进展。
Biochem Genet. 2022 Feb;60(1):223-240. doi: 10.1007/s10528-021-10084-5. Epub 2021 Jun 24.
7
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.Hippo 通路效应因子 TAZ 在小鼠中诱导肝内胆管癌,并在人类疾病中普遍激活。
J Exp Clin Cancer Res. 2022 Jun 3;41(1):192. doi: 10.1186/s13046-022-02394-2.
8
Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients.表观遗传失调介导的 COL12A1 上调预示着肝内胆管癌患者预后不良。
Clin Epigenetics. 2023 Jan 24;15(1):13. doi: 10.1186/s13148-022-01413-5.
9
Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.蛋白酪氨酸磷酸酶PTP4A1通过PI3K/AKT途径促进肝内胆管癌的增殖和上皮-间质转化。
Oncotarget. 2016 Nov 15;7(46):75210-75220. doi: 10.18632/oncotarget.12116.
10
Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.三结构域蛋白 59(TRIM59)的敲低通过 PI3K/AKT/mTOR 信号通路抑制胆管癌细胞的增殖。
Gene. 2019 May 25;698:50-60. doi: 10.1016/j.gene.2019.02.044. Epub 2019 Feb 27.

引用本文的文献

1
A nomogram integrating mutation signatures and clinical features for prognostic stratification in bladder cancer.一种整合突变特征和临床特征用于膀胱癌预后分层的列线图。
Discov Oncol. 2025 Aug 15;16(1):1562. doi: 10.1007/s12672-025-03338-w.
2
METTL14-mediated miR-122-5p maturation stimulated tumor progression by targeting KAT2A in hepatocellular carcinoma.在肝细胞癌中,METTL14介导的miR-122-5p成熟通过靶向KAT2A促进肿瘤进展。
Sci Rep. 2025 May 23;15(1):17884. doi: 10.1038/s41598-025-02129-1.
3
Glycomic profiling of parathyroid neoplasms via lectin microarray analysis.

本文引用的文献

1
Quantitative glycoproteomics analysis identifies novel FUT8 targets and signaling networks critical for breast cancer cell invasiveness.定量糖蛋白质组学分析鉴定了新型 FUT8 靶标和信号网络,这些靶标和信号网络对乳腺癌细胞的侵袭性至关重要。
Breast Cancer Res. 2022 Mar 18;24(1):21. doi: 10.1186/s13058-022-01513-3.
2
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma.蛋白质基因组学特征鉴定出肝内胆管癌的临床相关亚组。
Cancer Cell. 2022 Jan 10;40(1):70-87.e15. doi: 10.1016/j.ccell.2021.12.006. Epub 2021 Dec 30.
3
hnRNPA2B1-Mediated Extracellular Vesicles Sorting of miR-122-5p Potentially Promotes Lung Cancer Progression.
通过凝集素微阵列分析对甲状旁腺肿瘤进行糖组学分析。
Endocrine. 2025 Mar;87(3):1224-1234. doi: 10.1007/s12020-024-04107-5. Epub 2024 Nov 20.
4
Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer.非编码RNA在调控癌症中PI3K/Akt信号通路方面的新作用
Noncoding RNA Res. 2024 Aug 9;10:1-15. doi: 10.1016/j.ncrna.2024.08.002. eCollection 2025 Feb.
5
The Multifaceted Role of FUT8 in Tumorigenesis: From Pathways to Potential Clinical Applications.FUT8 在肿瘤发生中的多方面作用:从通路到潜在的临床应用。
Int J Mol Sci. 2024 Jan 15;25(2):1068. doi: 10.3390/ijms25021068.
6
Combined analysis of secreted proteins and glycosylation identifies prognostic features in cholangiocarcinoma.联合分析分泌蛋白和糖基化鉴定出胆管癌的预后特征。
J Cell Physiol. 2024 Mar;239(3):e31147. doi: 10.1002/jcp.31147. Epub 2023 Nov 3.
7
promotes colorectal cancer metastasis by excretion of miR-122-5p from cells via exosomes.通过外泌体将miR-122-5p从细胞中排出,从而促进结直肠癌转移。
iScience. 2023 Aug 19;26(9):107686. doi: 10.1016/j.isci.2023.107686. eCollection 2023 Sep 15.
8
Core fucosylation and its roles in gastrointestinal glycoimmunology.核心岩藻糖基化及其在胃肠道糖免疫中的作用。
World J Gastrointest Oncol. 2023 Jul 15;15(7):1119-1134. doi: 10.4251/wjgo.v15.i7.1119.
hnRNPA2B1 介导的细胞外囊泡分选 miR-122-5p 可能促进肺癌进展。
Int J Mol Sci. 2021 Nov 28;22(23):12866. doi: 10.3390/ijms222312866.
4
FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer.FUT8 介导的 B7H3 异常 N-糖基化抑制三阴性乳腺癌的免疫应答。
Nat Commun. 2021 May 11;12(1):2672. doi: 10.1038/s41467-021-22618-x.
5
Mevalonate Pathway Inhibition Slows Breast Cancer Metastasis via Reduced -glycosylation Abundance and Branching.甲羟戊酸途径抑制通过减少糖基化丰度和分支减缓乳腺癌转移。
Cancer Res. 2021 May 15;81(10):2625-2635. doi: 10.1158/0008-5472.CAN-20-2642. Epub 2021 Feb 18.
6
cFUT8 promotes liver cancer progression by miR-548c/FUT8 axis.cFUT8通过miR-548c/FUT8轴促进肝癌进展。
Signal Transduct Target Ther. 2021 Jan 27;6(1):30. doi: 10.1038/s41392-020-00393-3.
7
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.癌症中的糖基化改变:生物标志物和治疗的有希望的靶点。
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188464. doi: 10.1016/j.bbcan.2020.188464. Epub 2020 Nov 4.
8
MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma.微小RNA-342-3p是肝细胞癌中一种有效的肿瘤抑制因子。
J Hepatol. 2021 Jan;74(1):122-134. doi: 10.1016/j.jhep.2020.07.039. Epub 2020 Jul 30.
9
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.胆管癌 2020:机制和管理的新前沿。
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z. Epub 2020 Jun 30.
10
Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway.外泌体 MALAT1 通过海绵吸附 miR-26a/26b 促进结直肠癌细胞侵袭转移及其机制研究
J Exp Clin Cancer Res. 2020 Mar 24;39(1):54. doi: 10.1186/s13046-020-01562-6.